Follow-The-Filings

Security · featured owners

VIR

Vir Biotechnology Inc. COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.9%
  • $5M
  • 1 reduce 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 0.9% (David Witzke - Avidity Pa...) · not free-float ownership

  1. David Witzke reduce 0.9%

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
David Witzke - Avidity Partners Management 2026 Q2 0.9% Reduce −45.3% 519,300 $5M hist
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0% Exit 0.00 pp 22,000 $197K hist

1 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $74.2M $68.56M
Gross profit * — $73.36M $68.53M
Gross margin * — 98.9% 100.0%
Net income -$615.12M -$521.96M -$437.99M
Net margin * — -703.4% -638.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.59B $1.04B $514.08M
Total non-current assets * $330.83M $356.36M $488.74M
Total assets $1.92B $1.4B $1B
Total current liabilities $175.41M $119.66M $92.82M
Total non-current liabilities * $153.42M $128.77M $144.73M
Total equity — — —

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$778.78M -$446.35M -$391.78M
Cash from investing $164.63M $499.37M $310.37M
Cash from financing $7.48M $4.39M $3.78M
Net change in cash -$606.68M $57.4M -$77.62M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders